Wheeler Craig A Insider Trades

Insider Trading History

Track insider trading activity for Wheeler Craig A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.16M 28,195 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$602k 14,684 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$1M 24,444 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$327k 7,961 shares
$41.03
$41.03
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$282k 19,473 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$435k 30,000 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$235k 16,236 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.08M 74,872 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$442k 30,474 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$615k 42,467 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$523k 36,111 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$658k 45,423 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$269k 18,574 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.23M 84,631 shares
$14.50
$14.49
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1M 24,444 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 7,961 shares
$25.12
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $602k 14,684 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$369k 14,684 shares
$25.12
$41.03
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $1.23M 84,631 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 74,872 shares
$5.96
$14.49
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.16M 28,195 shares
Last Trade
Apr 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$513k 28,195 shares
$18.20
$41.03
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $931k 64,217 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 42,467 shares
$10.27
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $759k 52,370 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 30,474 shares
$12.62
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up